av/structure_therapeutics--big.svg

NASDAQ:GPCR

Structure Therapeutics

  • Stock

27.33

+1.22%

9.39

USD last updated 28/07 01:48:46

Last Close

17.94

25/07 20:01

Market Cap

2.25B

Beta: -

Volume Today

656.36K

Avg: 1.02M

PE Ratio

−22.22

PFCF: −22.62

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 ...Show More

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22021-12-302023-02-032023-03-312024-03-082024-11-132025-05-07

    Revenue (Estimate*)

    0.000.000.010.010.012021-12-302023-02-032023-03-312024-03-082024-11-132025-05-07

    *Estimate based on analyst consensus